clinical evaluation

clinical evaluation

Medtalk An evaluation of whether a Pt has symptoms of a disease, is responding to treatment, or is having adverse reactions to therapy
References in periodicals archive ?
The CE-marked BGM Galectin-3 test is marketed in Europe to help determine the prognosis of patients diagnosed with acute and chronic heart failure when used in combination with clinical evaluation. The product is also CE-marked to help the assessment of the risk of new onset heart failure in adults.
M2 EQUITYBITES-August 6, 2013-ViroPharma to cancel Phase II clinical evaluation of subcutaneous Cinryze(C)2013 M2 COMMUNICATIONS http://www.m2.com
The diagnosis is based on clinical evaluation of symptoms and the course of events and provides the basis of a treatment plan.
Among the topics are the evolution of concepts in flexor tendon surgery of the hand, frozen shoulder, the biomechanical and clinical evaluation of tendons and ligaments, and tissue engineering strategies for the regeneration of the anterior cruciate ligament.
The company added the IRB approval enables the commencement of a clinical evaluation of Symphony that will support its CE Mark Technical File.
PPI-668 is the company's second NS5A inhibitor to progress to clinical testing after Phase 1 clinical evaluation of PPI-461.
The company said that these clinical trials include patients presenting to the emergency department with chest pain and undergoing clinical evaluation including the performance of Positron Emission Tomography coupled to Computerized Axial Tomography (PET/CT) to detect the presence or absence of myocardial ischemia (523 patients enrolled), patients presenting with stroke symptoms (850 patients enrolled) and in trauma patients including traumatic brain injury where we already published favourable results (more than 3500 patients enrolled).
The Swiss company said that GVXN SD133 is its first product to enter clinical evaluation.
Psoriasis has been selected by Idera as the initial indication for the first clinical evaluation of IMO-3100 in patients with autoimmune disease.
Leading European Union centres began initial clinical evaluation of the Trevo System following receipt of the CE Mark in late 2009.
Presidio plans to launch early clinical development Phase Ib and Phase IIa of its novel HCV NS5A inhibitors, with subsequent Phase II-III clinical evaluation of such NS5A candidates in suitable combination regimens with other HCV antivirals through corporate partnering or intercompany collaborations.
Leading EU centers began initial clinical evaluation of the Trevo System following receipt of CE Mark in late 2009.

Full browser ?